Healthcare Tech: What Legal Pitfalls Should Tech Companies Avoid As They Jump Into Healthcare? | Latham & Watkins LLP

To embed, copy and paste the code into your website or blog:
The US regulators have been particularly focused on new players in the health tech space and the novel regulatory issues their products present within the existing legal framework. While the market is ripe with opportunity for innovative healthcare delivery models, tech companies should proceed with caution and ensure they understand the complex rigors and requirements of US healthcare regulations and enforcement regimes.
In this episode of our Connected With Latham podcast series, Washington D.C. See more +
The US regulators have been particularly focused on new players in the health tech space and the novel regulatory issues their products present within the existing legal framework. While the market is ripe with opportunity for innovative healthcare delivery models, tech companies should proceed with caution and ensure they understand the complex rigors and requirements of US healthcare regulations and enforcement regimes.

Related Keywords

Boston ,Massachusetts ,United States ,Washington ,John Manthei ,David Tolley ,Healthcare Life Sciences Industry Group ,Litigation Trial Department ,Healthcare Life Sciences Practice ,Connected With Latham ,Global Chair ,Life Sciences Practice ,Terra Reynolds ,Global Vice Chair ,Life Sciences Industry Group ,Trial Department ,போஸ்டன் ,மாசசூசெட்ஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,வாஷிங்டன் ,டேவிட் டோலி ,சுகாதாரம் வாழ்க்கை அறிவியல் தொழில் குழு ,வழக்கு சோதனை துறை ,சுகாதாரம் வாழ்க்கை அறிவியல் ப்ர்யாக்டீஸ் ,இணைக்கப்பட்டுள்ளது உடன் லாதம் ,உலகளாவிய நாற்காலி ,வாழ்க்கை அறிவியல் ப்ர்யாக்டீஸ் ,டெர்ரா ரெனால்ட்ஸ் ,உலகளாவிய துணை நாற்காலி ,வாழ்க்கை அறிவியல் தொழில் குழு ,சோதனை துறை ,